What are the diagnostic criteria, severity grading, and management recommendations according to the Tokyo guidelines for acute cholecystitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Tokyo Criteria for Acute Cholecystitis

The Tokyo Guidelines (TG13/TG18) provide a structured three-component diagnostic framework requiring clinical signs, laboratory findings, and imaging confirmation, with severity grading (Grade I-III) that directly determines management strategy from early laparoscopic cholecystectomy to gallbladder drainage. 1

Diagnostic Criteria

Diagnosis requires the presence of findings from all three categories 2, 1:

A. Local Signs of Inflammation

  • Murphy's sign (most useful clinical finding with positive LR 2.8)
  • Right upper quadrant pain or tenderness
  • Palpable mass/pain/tenderness in RUQ

B. Systemic Signs of Inflammation

  • Fever (>38°C or 100.4°F)
  • Elevated inflammatory markers:
    • Elevated C-reactive protein
    • Elevated white blood cell count
    • Neutrophil count (70% sensitivity, 65.8% specificity) 2

C. Imaging Findings (Required for Definite Diagnosis)

Imaging confirmation is mandatory - suspected diagnosis based on clinical/lab findings alone is insufficient 3, 4. Ultrasound, CT, or HIDA scan showing:

  • Gallbladder wall thickening
  • Pericholecystic fluid
  • Gallbladder distension
  • Sonographic Murphy's sign

Critical diagnostic caveat: No single feature has sufficient diagnostic power to establish or exclude acute cholecystitis - never rely on a single clinical or laboratory finding 2. The TG13 criteria achieved 91.2% sensitivity and 96.9% specificity when properly applied 4.

Severity Grading

The Tokyo Guidelines classify acute cholecystitis into three grades that directly determine treatment approach 1, 3:

Grade I (Mild)

  • Acute cholecystitis in a healthy patient
  • No organ dysfunction
  • Mild inflammatory changes in gallbladder

Grade II (Moderate)

Any ONE of the following:

  • Elevated WBC count (>18,000/mm³)
  • Palpable tender mass in RUQ
  • Duration of symptoms >72 hours
  • Marked local inflammation (gangrenous cholecystitis, pericholecystic abscess, hepatic abscess, biliary peritonitis, emphysematous cholecystitis)

Grade III (Severe)

Acute cholecystitis with organ dysfunction in ANY of the following:

  • Cardiovascular dysfunction (hypotension requiring dopamine ≥5 μg/kg/min or any dose of norepinephrine)
  • Neurological dysfunction (decreased consciousness)
  • Respiratory dysfunction (PaO2/FiO2 ratio <300)
  • Renal dysfunction (oliguria, creatinine >2.0 mg/dL)
  • Hepatic dysfunction (PT-INR >1.5)
  • Hematological dysfunction (platelet count <100,000/mm³)

The severity grading has been extensively validated and significantly correlates with 30-day mortality, length of hospital stay, conversion rates to open surgery, and medical costs 1.

Management Recommendations Based on Severity

Grade I (Mild): Early Laparoscopic Cholecystectomy

  • Perform early laparoscopic cholecystectomy (within 72 hours of symptom onset ideally, but safe up to 7-10 days)
  • This is the definitive first-line treatment 2

Grade II (Moderate): Early Laparoscopic Cholecystectomy

  • Early laparoscopic cholecystectomy remains preferred
  • Can proceed with surgery even in elderly patients (>80 years), pregnant women (any trimester), and patients with cirrhosis 5
  • If conservative treatment fails, proceed to cholecystectomy or drainage

Grade III (Severe): Individualized Approach

Immediate laparoscopic cholecystectomy is superior to percutaneous drainage even in high-risk patients 2. The landmark CHOCOLATE trial (APACHE score 7-14) demonstrated:

  • 5% complications with early cholecystectomy vs. 53% with drainage
  • Equal mortality between groups
  • Significantly fewer recurrent biliary events with surgery
  • Less healthcare resource utilization

However, for patients truly not suitable for surgery (extreme physiologic derangement):

  • Perform gallbladder drainage (percutaneous transhepatic or endoscopic ultrasound-guided) 2
  • This converts a septic patient into a non-septic patient
  • Consider delayed cholecystectomy after risk reduction

Important Clinical Pitfalls

Diagnostic sensitivity limitations: Studies show TG13 criteria may miss up to 47% of pathologically-confirmed acute cholecystitis cases 6. Many patients lack classic fever (only 4% febrile on presentation) or leukocytosis (49% without leukocytosis) 6. When clinical suspicion is high despite incomplete Tokyo criteria, imaging becomes even more critical.

Overuse of conservative management: The 2020 WSES guidelines emphasize that observation carries a 6.63-fold increased risk of gallstone-related complications compared to surgery 2. While 40% of patients may avoid surgery with conservative management, this approach has high recurrence rates and should not be the default for surgical candidates.

Age is not a contraindication: Healthy octogenarians can safely undergo laparoscopic cholecystectomy and should not be automatically relegated to non-operative management based on age alone 7.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.